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Abstract
Vitamins play important roles in female health. They are essential for many 
functions, including menstruation and ovulation, oocyte (egg) quality and matura-
tion. Vitamin E was first discovered in 1922 as a substance necessary for reproduc-
tion. It has become widely known as a powerful lipid-soluble antioxidant. There are 
various reports on the benefits of vitamin E on health in general. Vitamin E helps 
your body create and maintain red blood cells, healthy skin, eyes  and strengthens 
your natural immune system. However, despite it being initially discovered as a 
vitamin necessary for reproduction, to date studies relating to its effects in this area 
are lacking. Vitamin E supplementation may help reduce the risk of pregnancy com-
plications involving oxidative stress, such as pre-eclampsia. This chapter is written 
to provide a review of the known roles of vitamin E in pregnancy.
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1. Introduction
Vitamin E is an important micronutrient in the human body. Vitamin E main-
tains various body functions. It plays a very important role in maternal health 
and child development [1]. Vitamin E is an essential fat-soluble micronutrient for 
higher mammals and functions as an antioxidant for lipids [2]. American scientists 
Herbert McLean Evans and Katherine Scott Bishop discovered vitamin E in 1922. 
Vitamin E is an essential lipid-soluble vitamin. It was initially denoted as an “anti-
sterility factor X” that was necessary for reproduction. The vital role of vitamin 
E in reproduction was first investigated 80 years ago [3]. It was named according 
to a consecutive alphabetical order preceded by the discovery of vitamins A to D. 
Later vitamin E was called alpha-tocopherol, according to the Greek term “tokos” 
childbirth, “phero” to bear, and -ol indicating alcohol. Vitamin E is also called 
the “protecting vitamin” [4]. The amount of vitamin E is determined by age. For 
adults, the safest dose of vitamin E supplements is 1,500 IU/day for natural forms 
and 1,000 IU/day for man-made (synthetic) forms. Table 1 shows the average daily 
prescribed doses as determined by the Food and Nutrition Board of the Institute of 
Medicine [5–7].
Some vitamin E containing foods include wheat, rice bran, barley, oat, coconut, 
palm, and annatto [8–9]. Other sources include rye, amaranth, walnut, hazelnut, 
poppy, sunflower, maize and the seeds of grape and pumpkins [10]. The richest 
sources are nuts, spinach, whole grains, olive oil, and sunflower oil [11]. Vitamin E 
now refers to eight different isoforms that belong to two categories, four saturated 
analogues (α, β, γ, and δ) called tocopherols and four unsaturated analogues  
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(α, β, γ, and δ) referred to as tocotrienols [12]. α-, β-, γ- and δ-homologues contain 
three, two, two and one methyl groups, respectively. These structural differences 
and isomerism determine the biological activity [13]. Tocotrienols differ in the 
presence of 3 double bonds in their side chain from tocopherols. The position of the 
methyl groups on the chromanol ring varies between the tocopherol and tocotrienol 
isomers. Tocopherols can form 8 stereoisomers due to the presence of 3 asymmetri-
cal carbons in their side chains (RRR, RRS, RSR, RSS, SRR, SRS, SSR, SSS) [14]. 
Among these isomers, α-tocopherol (Figure 1) has the highest biologically active 
form [15]. α-tocopherol is the most abundant in plasma, cell membranes, other 
human tissues, and nutritional supplements, whereas γ-tocopherol is the primary 
form found in the human diet [16]. Tocopherols and tocotrienols, collectively 
known as tocols, are phenolic compounds. Although phenolic and polyphenolic 
compounds such as phenolic acids, flavonoids, anthocyanins, proanthocyanidins, 
and ellagitannins have received much attention due to their antioxidant activities 
and potential health benefits [17, 18].
Natural and synthetic forms of the tocopherols and tocotrienols are equally 
absorbed from the intestinal lumen in the form of mixed micelles. After the pas-
sage of the micelles into the intestinal mucosa, chylomicrons are synthesized to 
transport vitamin E from the intestinal mucosa through the lymphatic system to the 
circulatory system [19]. In plasma, alpha-tocopherol is found in all lipoprotein frac-
tions but mostly is associated with apo B-containing lipoproteins. Via the action of 
lipoprotein lipase (LPL), extrahepatic tissues pick up parts of the tocopherols trans-
ported in chylomicrons, and the remaining chylomicrons transport the remaining 
tocopherols to the liver. Here, a large proportion of alpha-tocopherol is incorporated 
into nascent very-low-density lipoproteins by the operation of the “alpha-tocoph-
erol transfer protein” (VLDL), whereas the excess of alpha-tocopherol plus the 
other forms of vitamin E is excreted in bile. When VLDL is secreted into circula-
tion, the action of LPL transforms VLDL into IDL and LDL, and the excess surface 
components, including alpha-tocopherol, are transferred to HDL. In addition to the 
LPL action, alpha-tocopherol is transmitted to tissues via the absorption of lipopro-
teins by different tissues through their corresponding receptors [20–24].
Metabolism of vitamin E begins with one cycle of CYP4F2/CYP3A4-dependent 
ω-hydroxylation followed by five cycles of subsequent β-oxidation and forms 
the water-soluble end-product carboxyethyl hydroxy chroman. α-Tocopherol 
can be oxidized to the tocopheroxyl radical. Further oxidation of the tocopher-
oxyl radical forms tocopheryl quinone. Other Metabolites of vitamin E include 
Life stage Recommended Amount
Birth to 6 months 4 mg/day
Infants 7 to 12 months 5 mg/day
Children 1 to 3 years 6 mg/day
Children 4 to 8 years 7 mg/day






Recommended Dietary Allowances (RDAs) for Vitamin E.
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2,5,7,8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman (α-CEHC) derived 
from α-tocopherol and 2,7,8-trimethyl-2- (2′-carboxyethyl)-6-hydroxychroman 
(γ-CEHC) derived from γ-tocopherol. There are two primary pathways for the 
excretion of vitamin E. Bile, which is then excreted in the urine, is the primary path 
of excretion. The second path is in the urine to make it more water-soluble after 
vitamin E is chain-shortened in a process similar to beta-oxidation. The major route 
of excretion of ingested vitamin E is fecal elimination because of its relatively low 
intestinal absorption [25, 26].
Because of its antioxidant function, it has several significant functions within 
the body. Numerous potential complications and disorders, including cancer, dia-
betes, arthritis and cataracts, have been related to oxidation; vitamin E is beneficial 
against these conditions. Vitamin E may also prevent platelet hyper aggregation, 
which can lead to atherosclerosis; it also helps to reduce the development of prosta-
glandins, such as thromboxane, that cause platelet clumping [27].
2. Role of vitamin E in pregnancy
Vitamin E supplementation may help reduce the risk of pregnancy complica-
tions involving oxidative stress. There is a need to evaluate the efficacy and safety 
of vitamin E supplementation in pregnancy [28]. A lack of vitamin E can lead to 
female infertility, miscarriage, premature delivery, eclampsia, fetal intrauterine 
growth restriction and other diseases associated with pregnancy [29–31]. Here some 
conditions in which vitamin E role are being described:
2.1 Infertility
Due to excessive production of ROS and/or insufficient consumption of anti-
oxidants, oxidative stress arises. When the generation of reactive oxygen species 
(ROS) and other radical species exceeds then scavenging ability of antioxidants fail, 
injury to cells can occur. The mitochondrial respiratory chain produces the majority 
of ROS, although they may also be generated through exogenous exposures such as 
alcohol, cigarette smoke, and environmental pollutants. Antioxidants (such as vita-
mins C and E) and antioxidant cofactors (such as selenium, zinc, and copper) can 
dispose of, scavenge, or suppress the formation of reactive oxygen species (ROS). 
Reduced sperm motility, sperm number, and sperm–oocyte fusion have all been 
linked to oxidative stress in male infertility. In women, several animal and in-vitro 
studies suggest that oxidative stress may affect female fertility. Adequate intake of 
vitamin E protects from free radical generation [32].
According to Cooper et al., vitamin E deficiency impaired both male and female 
rats’ germ cells. Vitamin E deficiency has a significant impact on secondary sper-
matocytes and spermatids [33]. According to several studies, vitamin E deficiency 
has been linked to reduced fertility in both humans and lab animals. Rengaraj et al. 
Figure 1. 
Chemical Structure of alpha-Tocopherol.
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discovered that a moderate amount of vitamin E in poultry diet preserves semen/
sperm quality in male birds and egg quality in female birds by reducing lipid peroxi-
dation in semen/sperms and eggs [34]. The effects of vitamin E on sperm motility 
were studied by Suleiman et al. A total of 11 out of 52 treated patients (21%) were 
pregnant, and 31 subjects experienced increased sperm motility [35]. In a system-
atic review of the effect of oral antioxidants (vitamins C and E, zinc, Se, carnitine) 
on male infertility by Ross et al., 17 randomized trials, including a total of 1665 
men, were identified. Of the 17 trials, 14(82%) showed an improvement in either 
sperm quality or pregnancy rate after antioxidant therapy [36]. Cicek et al., studied 
the impact of vitamin E on the treatment results of women who were going through 
intrauterine insemination and controlled ovarian stimulation and had an unknown 
cause of infertility. Two groups A and B had 53 and 50 volunteers respectively. 
Group A received 400 IU/day of vitamin E and clomiphene citrate. This combina-
tion was used for producing controlled ovarian stimulations. Group B (control) 
also received controlled ovarian stimulation but without vitamin E. Outcome of the 
study demonstrated that both the groups had a significant difference in the thick-
ness of endometrium on the day which human chorionic gonadotropin (hCG) was 
administered. Nevertheless, implantation and pregnancy rates had no connection 
with the administration of vitamin E. Based on the study it can be concluded that 
vitamin E possesses antioxidant effect and its administration could enhance the 
response of endometrium in females with unknown cause of infertility [37]. Das 
et al. performed a study in which female rats (30 days age) were maintained on a 
vitamin E-deficient diet for 70 days. At 100 days of age, the vitamin E-deficient 
and control animals were sacrificed. A group of animals was supplemented with 
a normal diet for the last 25 days following a 45-day deficient diet, or vice versa. 
The most notable findings were (i) a significant decrease in uterine weight in the 
deficient group, (ii) a significant decrease in estrogen, LH, and estrogen-induced 
uterine enzymes alkaline phosphatase and peroxidase, and (iii) ovarian dysfunction 
as shown by degenerating graffian follicles [38].
2.2 Endometriosis
Endometriosis is a condition characterized by the presence of endometrial tissue 
outside the uterine cavity [39]. Endometriosis is a condition that affects mostly 
women of reproductive age. The peak incidence is between 35 and 45 years old 
[40]. Endometriosis is found in 25 to 40% of women with infertility and 40–87% 
of women with chronic pelvic pain have endometriosis [41–43]. Endometriosis is 
associated with oxidative stress, even though the pathogenesis of the condition is 
currently unknown. Patient with endometriosis have an altered balance of prooxi-
dant and antioxidant molecules [44–46].
Santanam et al. performed a randomized, placebo-controlled trial of antioxidant 
vitamins (vitamin E and C) in women with pelvic pain and endometriosis. This 
study included 59 women between the ages of 19 and 41 who had pelvic pain and 
had a history of endometriosis or infertility. Before surgery, patients were randomly 
assigned to one of two groups: vitamin E (1200 IU) and vitamin C (1000 mg) or 
placebo for eight weeks. Results indicated that after treatment with antioxidants, 
chronic pain (“everyday pain”) improved in 43 percent of patients in the antioxi-
dant treatment group (P = 0.0055) compared with the placebo group. The results 
of this clinical trial show that administration of antioxidants reduces chronic pelvic 
pain in women with endometriosis and inflammatory markers [47]. East-Powell 
et al. performed a randomized, placebo-controlled trial of antioxidant vitamins 
(vitamin E and C) in women with pelvic pain and endometriosis and/or infertility. 
A total of 59 women were included in the trial. Patients were randomly assigned to 
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2 groups: vitamin E 1200 IU (3 capsules of 400 mg each) and vitamin C 1000 mg 
(2 tablets of 500 mg each) daily for eight weeks before surgery. The results of this 
clinical trial show that administration of antioxidants (vitamin E and C) reduces 
chronic pelvic pain in women with endometriosis and inflammatory markers [48]. 
Hashemi et al. performed a randomized clinical trial in 40 women with implanta-
tion failure aged 18–37 years old. Participants were randomly divided into two 
groups: group A received 400-IU vitamin E supplements and group B received a 
placebo for 12 weeks. Vitamin E supplements were shown to dramatically improve 
serum vitamin E levels and endometrial thickness in women with implantation fail-
ure [49]. Kavtaradze et al. performed a clinical trial in 59 patients age 19–41 years 
with pelvic pain and history of endometriosis and/or infertility. Patients were 
randomly assigned to 2 groups: vitamin E (1200 IU) and vitamin C (1000 mg) 
combination or placebo daily for two months before surgery. This clinical trial’s 
preliminary findings indicate that antioxidants (vitamins E and C) improve pelvic 
pain in women with endometriosis. According to this report, antioxidant vitamins 
are effective in reducing chronic pelvic pain in women with endometriosis. This 
research supports the development of a new class of medicines for the treatment of 
endometriosis-related pelvic pain. This information further supports our overall 
conclusion that endometriosis is an oxidative stress-related condition [50].
2.3 Miscarriage
Miscarriage is a serious pregnancy complication that can be brought about by a 
variety of causes. Vitamin deficiency has been linked to an increased risk of miscar-
riage, so supplementing women with vitamins before or during pregnancy can help 
prevent miscarriage [51]. Vitamin E deficiency’s effects on human health have yet 
to be thoroughly reported and investigated. Low plasma vitamin E, on the other 
hand, has been linked to miscarriage in the first trimester of a woman’s pregnancy. 
Furthermore, vitamin E supplementation in the diet reduced the rate of miscarriage 
in pregnant women by around 50% [52].
Pregnant women have quicker metabolism, increased production of free radi-
cals, and increased lipid peroxidation. Thus, low levels of vitamin E can lead to 
the production of excessive free radicals, leading to placental aging, endothelial 
vascular damage, which increases the incidence of high-risk infections in pregnancy 
[53, 54]. It can also damage the lining of the fetal cell membranes, increasing the 
risk of premature rupture of the embryo [55]. Increased reactive oxygen species 
and decreased antioxidant levels in men are associated with recurrent miscarriage 
(RM). Antioxidant therapy has recently been recognized as a way to improve sperm 
parameters. Pourmasumi et al. evaluate the effect of paternal factor and antioxidant 
therapy on sperm parameters in couples with RM. Sixty samples with RM patients 
were analyzed before and after 3 months of vitamin E and selenium therapy. Results 
of this study show that antioxidants can improve sperm parameters and chromatin 
condensation in recurrent miscarriage male partners [56].
Vitamin E has anticoagulant activity; excessive vitamin E can have an impact 
on blood clotting in the fetus, increasing the risks of high levels of bilirubin and 
nuclear jaundice for newborn babies. Also, excessive vitamin E has an antagonistic 
effect on other fat-soluble vitamins in the blood of pregnant women, preventing the 
absorption and functions of other vitamins. As a result, clinicians should pay care-
ful attention to changes in vitamin E levels during pregnancy and offer appropriate 
dietary advice, with an emphasis on reasonable vitamin E supplementation [57].
Kurmacheva et al. conduct a pharmacoeconomic analysis of two schemes of vita-
min-mineral drugs in the peri-gestation period in women. In two classes of women, 
the cost-effectiveness of vitamin-mineral formulations was calculated. Patients in 
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the first group (n = 60) were given a vitamin-mineral complex before and during 
pregnancy that included metafolin, other B vitamins, vitamins C, E, PP, and iodine 
(150 mcg) in physiological doses, as well as 200 mg of docosahexaenoic acid in a 
capsule intended for use from the 13th week until the end of pregnancy. During 
pregravid preparation and the gestational period, women in the second group 
(n = 54) took high doses of synthetic folic acid, vitamins B6 and B12 as part of two 
vitamin and mineral preparations. The use of vitamin-mineral complex containing 
physiological dosages of vitamins of group B, vitamins C, E, PP and iodine in the 
peri-gestation period in women with habitual miscarriages has tangible clinical 
and economic advantages in comparison with the administration of high doses of 
synthetic folic acid, vitamins B6 and B12 [58].
Shamim et al. studied the contribution of deficiencies of vitamin E to human 
pregnancy loss (pregnancy losses <24 wk. of gestation) in rural Bangladesh. A 
trial was done in 1605 pregnant Bangladeshi women, gestational age: 8–13 weeks. 
Of the 1,605 women in the study, 141, or 8.8%, miscarried. About 5.2% of women 
with adequate alpha-tocopherol miscarried in the first or second trimester, com-
pared with 10.2 percent of women with low levels. It was found that low plasma 
α-tocopherol was associated with an increased risk of miscarriage. Maternal vitamin 
E status in the first trimester may influence the risk of early pregnancy loss [59].
Junovich et al. investigate the fertility properties of Vitamin E. Pregnant 
females from CBA/J × DBA/2 miscarriage model (creates an immune type miscar-
riage) were orally supplemented with Vitamin E (15 mg/day). It was found that 
Vitamin E has able to decrease the miscarriage rate [60]. Şimşek et al. investigated 
plasma levels of vitamin E in 40 women with habitual abortion (HA) at the 
Department of Obstetrics and Gynaecology, Medical Faculty of Firat University, 
ElazigÏ, Turkey. The mean age of the patients was 28.5 years (21 ± 38 years). The 
levels of vitamin E were significantly lower in women with HA than in controls. 
According to the results of this study, it was found that a level of vitamin E 
was significantly decreased (P < 0.01) in HA. The decrease of this antioxidant 
may play a significant role in women with habitual abortion [61]. Vural et al. 
performed a clinical trial to determine the relationship between changes in some 
parameters of the antioxidant system like vitamin E and recurrent abortion. For 
the study 120 women with recurrent abortions, 25 non-pregnant healthy women 
in the productive era and 25 normotensive pregnant women within their first 
trimester were taken into the study in Istanbul Medical Faculty, Gynecology and 
Obstetric Department. According to the etiology, women with chronic miscar-
riage were classified into four subgroups: autoimmune, luteal phase defect, 
anatomical disease, and unexplained. Vitamin E levels in the autoimmune, 
unexplained, and luteal phase defect subgroups were slightly lower than in the 
two control groups and the anatomical defect group. It was found that decreased 
concentrations of plasma vitamin E reflect the increased oxidative stress. In a 
conclusion, recurrent miscarriages may also result in oxidative stress and deple-
tion and weakness of antioxidant defence [62].
Von Mandach et al. studied that whether there is an association between reduced 
vitamin E levels and abnormal pregnancy. Abnormal pregnancies were compared 
with normals. In normal pregnancies, mean vitamin E levels rose from 12.9 +/− 1.1 
micrograms/ml in early pregnancy to 22.5 +/− 1.5 micrograms/ml at term (p < 0.05, 
n = 11). In pregnancies with fetal complications or maternal risks, vitamin E levels 
were lower than in normal at corresponding gestational age. The results show lower 
maternal levels of vitamin E in abnormal pregnancies [63].
Oladimeji et al. performed a clinical trial to examine the relationship between 
serum vitamin E levels and unexplained infertility and recurrent miscarriages. 
Eighty-two healthy Nigerian Women volunteers were recruited for this study. The 
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mean serum vitamin E concentration in pregnant women was found to be insignifi-
cantly higher (10.36 ± 3.52 mg/ml) than the reported values in women with unex-
plained infertility and persistent miscarriage (8.97 ± 3.56 mg/ml). It was concluded 
from this study that there is no relationship between recurrent miscarriages and 
unexplained infertility and vitamin E levels [64].
Miscarriage risk is significantly reduced by taking supplementary vitamin E 
(at least 200 IU and perhaps 400 IU daily). There were already results of medical 
reports confirming this by the end of WW II [65].
2.4 Polycystic ovary syndrome (PCOS)
Polycystic ovary syndrome is a common birth defect in women during child-
bearing age. According to the Endocrine Society released training strategies for 
PCOS, in adolescents with PCOS, metformin and hormonal contraceptives are the 
treatment options [66].
Vitamin E is not a hormone but acts as a hormone. It works by impersonating 
the effects of progesterone on the body, as well as by reducing the side effects of 
high levels of androgens (testosterone and estrogen). In a study after 12 weeks, 
the amount of serum testosterone decreased which provides evidence against it. 
The study also found that lifestyle changes and the use of supplements including 
omega-3 and/or Vitamin E will improve inflammation and insulin sensitivity thus 
remaining an effective treatment approach for PCOS subjects. Vitamin E may serve 
as a necessary supplement included in the current treatment guide to improve PCOS 
parameters, which will also improve the quality of life in PCOS and reduce overall 
medical costs, often unaffordable for most people with PCOS in India [67]. Vitamin 
E reacts often with lipid peroxyl radicals which leads to the elimination of peroxida-
tion chain reactions and thus reduces oxidative damage. The serum concentration 
of vitamin E in the study was significantly lower in PCOS patients compared with 
controls. Similar reports of reduced vitamin E concentration in PCOS patients 
were stated in various studies [68]. The prospect of a fast response of vitamin 
E to cellular oxygen and free radicals may be the cause of a significant decrease 
in vitamin E concentration. Therefore, it is proposed that vitamin E through its 
natural scavenging method protects polyunsaturated fatty acids from peroxida-
tion reactions [69]. Mohan et al. 2009 estimated plasma vitamin E level in fifty-six 
Polycystic Ovary Syndrome patients. It was observed that there was a significant 
decrease in plasma vitamin E levels in patients with polycystic ovary syndrome 
when compared to controls [70]. Hamad et al. studied the effect of vitamin E and 
selenium on ovulation in PCOS patients. The participants in this sample included 
25 PCOS patients who were untreated and 26 PCOS patients who were treated, as 
well as 42 healthy controls. From the results of this study, it was found that vitamin 
E has a significant role in the ovulation of PCOS patients [71]. Angiogenesis distur-
bances are common in women with polycystic ovary syndrome (PCOS). Shirazi et 
al. performed a randomized, double-blind, placebo-controlled trial on 43 women, 
ages 20–40 years, with PCOS to evaluate antiangiogenic properties of Vitamin 
E. Patients were randomly assigned into two groups: group A received vitamin E 
400 IU/day and group B received placebo for 8 weeks. At the start and end of the 
analysis, anthropometric and angiogenic parameters such as body weight, fat mass, 
and fat-free mass, vascular endothelial growth factor (VEGF), basic fibroblast 
growth factor (bFGF), angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) were 
calculated using standard methods. Vitamin E supplementation for eight weeks 
had beneficial effects on body weight, Ang-1, Ang-1/Ang-2 ratio, and VEGF level 
in PCOS women [72]. Carotid intima-media thickness (CIMT) artery in women 
with PCOS was significantly higher than healthy women. CIMT has been widely 
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used as a surrogate index of atherosclerosis and CVD events. Talari et al. performed 
a randomized, double-blind, placebo-controlled trial in 60 women with PCOS to 
evaluate the beneficial effects of omega-3 and vitamin E co-supplementation on 
carotid intima-media thickness (CIMT). Participants were randomly assigned into 
two groups and assigned to take either 1000 mg omega-3 plus 400 IU vitamin E 
supplements or a placebo for 12 weeks. It was found a significant reduction in maxi-
mum and mean levels of the left and right CIMT in patients with PCOS compared 
with placebo. Antioxidant and anti-inflammatory effects of Vitamin E may improve 
CIMT [73].
PCOS is a heterogeneous syndrome characterized by hyperandrogenism 
symptoms. Izadi et al. performed a randomized, double-blind, placebo-controlled 
clinical trial to evaluate the effects of CoQ10 and/or vitamin E on glucose homeo-
stasis parameters and reproductive hormones in women with PCOS. In this study, 
it was found that CoQ10 with or without vitamin E supplementation for 8 weeks 
among patients with PCOS significantly decreased serum total testosterone levels 
(P < 0.001) compared with those of the placebo group. CoQ10 supplementation in 
combination with vitamin E significantly improved sex hormone-binding globulin 
(SHBG) levels compared with other groups (P = 0.008) [74].
2.5 Embryonic development
Human embryonic development refers to the development and formation of the 
human embryo. It is characterized by the processes of cell division and cellular dif-
ferentiation of the embryo that occurs during the early stages of development [75].
ROS are highly reactive molecules, their accumulation can lead to damage and 
breakage of DNA strands. Many pieces of evidence have been found that ROS 
compromises embryo development in many species [76–78].
Selenium and Vitamin E are the important antioxidants that protect mammalian 
cells against lipid peroxidation. Tsujii et al. conducted a study to investigate whether 
Selenium or Vitamin E and Selenium + Vitamin E overcome the undesirable oxida-
tive stress produced by hydrogen peroxide (H2O2) and enhance the development 
of pre implanted mice embryo. Co-incubating the embryos with 60 nM Selenium 
and/or 100 nM Vitamin E were increased (P < 0.05) the blastocyst development 
rate. The addition of H2O2 reduced the development of mouse embryos, but the 
addition of Vitamin E, Se and Selenium+Vitamin E reduced the detrimental effect 
of H2O2 and influenced the higher rate of development to blastocysts, compared 
to CZB alone (P < 0.05). The incorporation and oxidation of 14C-glucose in the 
blastocysts developed by the medium supplemented with Se and/or Vitamin E in 
the presence or absence of H2O2 were significantly higher (P < 0.05) than that of 
the control. Moreover, Vitamin E is more effective than Selenium and Selenium + 
Vitamin E in reversing ROS-induced mouse embryotoxicity [79]. McDougall et al. 
studied the long-term effects of Vitamin E deficiency on embryonic development 
and improvement effect after feeding Vitamin E-adequate diets by using a zebrafish 
model. Adult zebrafish maintained on Vitamin E-deficient (E-) or sufficient (E+) 
diets up to 12 days post-fertilization (dpf) to obtained E- and E+ embryos. The 
E- group suffered significantly increased morbidity and mortality as well as altered 
DNA methylation status through 5 dpf when compared to E+ larvae, but upon 
feeding with a Vitamin E -adequate diet from 5 to 12 dpf both the E- and E+ groups 
survived and grew normally; the DNA methylation profile also was similar between 
groups by 12 dpf. However, 12 dpf E- larvae still had behavioral defects. Outcomes 
suggest that embryonic Vitamin E deficiency causes behavioral impairments due to 
persistent lipid peroxidation and metabolic perturbations that are not resolved via 
later dietary vitamin E supplementation [80].
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2.6 Pre-mature delivery
Every year, about 15 million babies (1 in 10) are delivered prematurely around 
the world. Prematurity is the second leading cause of death among newborns after 
pneumonia. Pre-mature babies struggle with visual, auditory and learning disabili-
ties. Over 60% of pre-mature delivery worldwide occurs in Sub-Saharan Africa and 
South Asia [81].
Cruz et al. studied the effect of vitamin E supplementation on mothers with 
threatened premature delivery and premature infants. It was found that maternal 
vitamin E treatment did not prevent either erythrocyte hemolysis or lipid peroxide 
formation in premature infants after birth. On the other hand, intramuscular 
vitamins E to infants after birth prevent erythrocyte hemolysis and low lipid 
peroxide formation when serum vitamin E increased above 2 mg/100 ml [82]. 
Hittner et al. performed a double-blind study in 101 preterm infants to evaluate the 
efficacy of oral vitamin E in preventing the development of retrolental fibroplasia. 
50 infants received vitamin E 100 mg/Kg/ day and 51 infants received 5 mg mg/Kg/
day (controls). The severity of retrolental fibroplasia was found to be significantly 
reduced in infants given 100 mg of vitamin E (P = 0.012) [83]. The link between 
vitamin E deficiency and hemolytic anemia in small premature infants prompted 
researchers to look into vitamin E absorption in infants of different gestational and 
developmental ages. Premature infants’ capacity to sustain vitamin E sufficiency 
during the first three months of life was shown to be directly related to their 
gestational age; infants with the lowest gestational age were the least likely to attain 
vitamin E sufficiency, even when given a vitamin E supplement. In infants with 
a gestational age of fewer than 32 weeks, there was a gradual increase in vitamin 
absorption in the intestine. Oral iron administration has been linked to a reduction 
in vitamin E absorption in the intestine. Since maintenance of vitamin E sufficiency 
appears to be nutritionally important in the premature infant, the efficacy of other 
routes of administration of the vitamin should be explored [84]. Vitamin E has 
been linked to several positive outcomes in premature newborn infants. Vitamin E 
deficiency is believed to be at least partially responsible for the anemia that happens 
often 4 to 6 weeks after premature birth, and regular vitamin E supplementation 
is often recommended. However, a review of published controlled trials of vitamin 
E supplementation shows that the extent, if any, of this preventive effect against 
anemia is debated. According to research, the dietary ratio of alpha-tocopherol to 
polyunsaturated fatty acids is normally sufficient to avoid symptoms of vitamin E 
deficiency without the use of supplements. Premature infants exposed to oxygen-
rich conditions and artificial ventilation are protected from the risks of retrolental 
fibroplasia and bronchopulmonary dysplasia by receiving large parenteral doses of 
vitamin E. However, subsequent research has yet to verify these positive early find-
ings of preventive effects. At this time, there does not seem to be any clear evidence 
that supplementing a premature infant’s usual vitamin E intake is essential. [85].
2.7 Uterine fibroids
Uterine fibroids or myomas are benign tumours of the human uterus. The main 
symptoms are prolonged or heavy menstrual bleeding, pelvic pressure or pain, and 
reproductive dysfunction [86]. Fibroids have an effect on a woman’s pregnancy as 
well as her quality of life. Fibroids affect approximately 35–77% of reproductive-
age women. Fibroids may cause infertility by obstructing the fallopian tubes and 
impairing gamete transport [87].
A total of 49 patients were enrolled in a double-blind, randomized, placebo-con-
trolled trial conducted by Harrison et al. in 2003. For six months, all patients were 
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given either vitamins E (1000 IU) and C (1000 mg) or a placebo. Results show that 
a statistically significant improvement in fibrosis score (p = 0.002) [88]. Fruscella 
et al. studied the effect of vitamin E (300 mg per day) in a group of 25 women, aged 
between 25 and 41 years old, suffering from uterine myomas in pregnancy. All the 
pregnancies continued to term. The neonatal outcome was satisfactory in all cases 
and no collateral effects were observed in either mothers or fetuses [89]. Tocopherol 
can stop cancer cells from growing in culture by trapping free radicals and other 
mechanisms [90]. Young et al. discovered that vitamin E succinate (a vitamin E ana-
logue) decreased the number of UF cells and caused cell death [91]. In addition, Zhang 
et al. discovered that vitamin E succinate ester could suppress steroid hormone 
signalling [92].
2.8 Preeclampsia
Preeclampsia is a major cause of both maternal and fetal neonatal morbidity. 
Endothelial damage in the arteries is believed to play a role. The simple clinical 
definition [gestational hypertension (>90 mmHg diastolic) occurring after the 20th 
week of gestation with superimposed proteinuria (>300 mg/day) belies the com-
plexity of preeclampsia, which is often accompanied by multi-organ dysfunction. 
Free radical-mediated lipid peroxidation may be involved in endothelial damage in 
preeclampsia. Complications such as endothelial cell dysfunction of blood vessels 
in women with preeclampsia and other hypertensive conditions are linked with 
oxidative stress and lipid peroxidation.
Antioxidants may be essential for lipid peroxidation prevention and, hypotheti-
cally, pre-eclampsia prevention. Vitamin E, which is a free radical scavenger and 
thus inhibits the development of lipid peroxides, opposes the toxic acts of lipid 
peroxides. It acts as in-vivo antioxidant that protects tissue lipids from free radical 
attack and thus stabilizes cell membranes. Compared to non-pregnancy, maternal 
levels of vitamin E are elevated in pregnancy, which is consistent with previous 
studies. In women with preeclampsia, the antioxidant function is decreased relative 
to women who have normal pregnancies. Antioxidant activity increases throughout 
normal gestation, but not with preeclampsia. It has been suggested that evidence 
of vitamin E consumption is an alerting mechanism for the development of pre-
eclampsia [93, 94]. Some preclinical studies show that vitamin E plays a role in 
preeclampsia [95]. But some clinical studies suggest that there is no role of vitamin 
E in preeclampsia [96, 97]. A study has found that level of vitamin E in preeclamp-
sia was low, but no preventive role was found in preeclampsia [98].
2.9 Intrauterine growth restriction
Intrauterine growth restriction (IUGR) is the inability of fetuses to achieve their 
genetically defined growth rate resulting in offspring with low birth weight (LBW) 
and is a problem for both human and veterinary medicine. IUGR has significant 
consequences for the mortality and morbidity of LBW newborns and has long-term 
effects on their development and health. The presence of IUGR is directly linked to 
an insufficient supply of nutrients and oxygen to the fetus due to maternal malnu-
trition and/or placental insufficiency [99, 100].
In the study, Sales et al. found that combined maternal administration of 
vitamin C and E in sheep was associated with increased levels of both vitamins in 
the fetal cord, enhanced antioxidant status, and increased fetal development in 
singleton and twin pregnancies, but with a greater impact on twin pregnancies. 
These findings demonstrate the ability of supplementation of vitamin C and E 
to reduce the effects of IUGRR [101]. Since the transplacental transmission of 
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alpha-tocopherol is minimal, newborns are considered an at-risk category for 
vitamin E deficiency. Low serum levels of alpha-tocopherol are associated with the 
development of edemas, thrombocytosis, and hemolytic anemia, which can result 
in cardiomyopathy and the possible consequence of this vitamin deficiency is its 
restriction on the intrauterine growth of fetuses [102].
Atherosclerosis is one of the main factor of intrauterine growth restriction. 
Busso et al., (2014) studied LDL KO mice diet-induced maternal hypercholester-
olemia and atherosclerosis during pregnancy can negatively impact fetal growth. 
Vitamin E dietary supplementation has a beneficial effect, preventing growth 
restriction in a significant proportion of fetuses from HC-fed mice [103].
2.10 Premature rupture of membranes
Preterm, premature rupture of the membranes (PPROM) is defined as mem-
brane rupture before 37 weeks’ gestation in the absence of labour.
PPROM occurs in 1–2% of all deliveries and results in a major portion of preterm 
deliveries with the regular mortality rate in neonates [104]. Infection, cigarette 
smoke, and inflammation have all been linked to preterm premature rupture of 
fetal membranes. Since hypochlorous acid (a reactive oxygen species) is essential 
to the body’s reaction to infection, it may cause tissue damage when destroying 
pathogens. Plessinger et al. found that antioxidant therapy (vitamins C and E) has a 
protective effect against hypochlorous acid-induced damage [105].
Preterm infants have a higher risk of oxidative stress and free-radical-
mediated diseases, which is partially due to their low antioxidant levels. Bolisetty 
et al. studied the effect of maternal supplementation of antioxidant vitamins 
before delivery to reduce the oxidative stress in the mothers and their infants. Five 
mothers between the ages of 30 and 36 weeks who were at risk of preterm delivery 
were given a daily oral dosage of betacarotene 20 mg, vitamin E 167.8 mg, and 
vitamin C 1000 mg until delivery. There was a trend of lower plasma MDA and 
higher vitamin E at birth in infants born to supplemented mothers. Finally, it has 
been concluded that short supplementation of antioxidant vitamins to preterm 
pregnant women reduced the oxidative stress at delivery in mothers and probably 
in their neonates [106].
The fetal membranes (amnion and chorion) derive their strength principally 
from collagen. Collagen provides fetal membranes with both tensile strength and 
elasticity. Reactive oxygen species (ROS) generated by the body’s response to infec-
tion, cigarette smoking, bleeding, or cocaine use can activate collagen lytic enzymes 
and impair fetal membrane integrity. Vitamin E, a lipid-soluble antioxidant, inhib-
its membrane-damaging effects of reactive oxygen species induced lipid peroxida-
tion [107]. Hauth et al., studied that maternal supplementation with vitamin C and 
E did not reduce the occurrence of spontaneous preterm birth [108].
3. Discussion
Several risk factors contributing to reproductive- and pregnancy-related 
disorders have been reported. Environmental and lifestyle factors are the two 
main types factors. Examples of major environmental pollutants include hazard-
ous man-made chemicals, industrial discharge, agricultural run-off, human 
and animal waste, municipal and domestic effluents, and spillage of vessels 
and oil spills [109]. Lifestyle factors represent another category of major risk 
factors for reproductive and pregnancy-related disorders. Unhealthy lifestyle 
behaviors, including cigarette smoking, alcohol consumption, and/or drug abuse, 
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have negative impacts, particularly on female fertility [110, 111]. Furthermore, 
exposure to multiple environmental pollutants may also result in reactive oxygen 
species (ROS)-induced oxidative stress (OS). High levels of OS can be linked to a 
variety of pregnancy-related issues, including embryonic death, early spontane-
ous abortion, IUGR, fetal death, preterm births, and low birth weight [112, 113]. 
ROS are highly reactive and unstable. They acquire electrons from nucleic acids, 
lipids, proteins, carbohydrates, or any other nearby molecule causing a string of 
chain reactions to become stable. These chain reactions result in cellular damage 
and diseases [114]. The human body produces reactive compounds known as free 
radicals which exert a positive as well as a negative impact on the body. To mini-
mize the harmful effect, a complex protection system is required which is known 
as the antioxidant system. When there is an imbalance between the production 
of free radicals and the defense mechanism of the antioxidant system it leads to 
a condition known as oxidative stress [115]. Oxidative stress affects the interac-
tion of gametes and their quality. Spermatozoa, embryos, and oocyte and their 
environment are affected by free radicals such as reactive oxygen species (ROS). 
The quality of sperm-mediated oocyte activation, early embryo development, 
implantation, sperm oocyte interaction is dependent on the microenvironment 
associated with peritoneal fluid, follicular fluid, and hydrosalpingeal fluid. 
Implantation and early embryo development are adversely affected by oxidative 
stress leading to a negative effect on the rate of pregnancy. One of the causative 
factors for infertility and endometriosis is oxidative stress [116]. ROS or pro-oxi-
dant or free radicals production have a connection with aerobic metabolism [117, 
118], and also the hormones, cytokines, and other stressors are associated with 
its production. Hydroxyl radical, superoxide anion and hydrogen peroxide are 
examples of reactive oxygen species (ROS) and they act by modulating the gene 
expression and transcription factor. A broad range of antioxidants is available 
which hold the capability to repair cell damage caused by ROS and can neutralize 
them as well [119, 120].
Some studies suggested that there is a direct relationship between the outcome 
of the pregnancy and the level of ROS. The placental mitochondrion is the place 
that has been identified for the production of superoxide in a great amount [121, 
122]. Antioxidants such as vitamin C and vitamin E have been reported to be 
efficient, and their uses in reproductive- and pregnancy-related disorders have been 
the subject of significant clinical trials [123]. Vitamin E is a chain-breaking antioxi-
dant that helps to inhibit lipid peroxidation [124, 125].
All of these studies show that vitamin E is essential for a natural and stable 
pregnancy and that vitamin E supplementation has no negative effects on preg-
nancy outcomes. As discussed above, vitamin E has been proven to be beneficial in 
pregnancy and neonatal health.
4. Conclusion
Vitamin E has antioxidant properties that may support pregnancy, but more 
research is needed to determine its effectiveness. There is a need to evaluate the 
efficacy and safety of vitamin E supplementation in pregnancy. More research is 
needed to accurately quantify antioxidant-like vitamin E levels in pregnancy and 
how they change throughout the pregnancy. It is necessary to investigate the effects 
of antioxidants on maternal, fetal, and placental health. Prenatal advice should 
be clear to ensure that women and physicians understand the dietary conditions 
during pregnancy and how a balanced diet contains antioxidant micronutrients like 
vitamin E will help avoid pregnancy-related diseases.
13
Role of Vitamin E in Pregnancy
DOI: http://dx.doi.org/10.5772/intechopen.97268
Author details
Mohd Aftab Siddiqui*, Usama Ahmad, Asad Ali, Farogh Ahsan  
and Md. Faheem Haider
Faculty of Pharmacy, Integral University, Lucknow, U.P., India
*Address all correspondence to: aftab.uzaiz@gmail.com
Conflict of interest
The authors declare no conflict of interest.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
14
Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects
[1] Bastani P, Hamdi K, Abasalizadeh F, 
Navali N. Effects of vitamin E 
supplementation on some pregnancy 
health indices: A randomized clinical 
trial. International journal of general 
medicine. 2011; 4:46.
[2] Takada T, Suzuki H. Molecular 
mechanisms of membrane transport of 
vitamin E. Molecular nutrition & food 
research. 2010 May; 54(5):616-22.
[3] Evans, H.M.; Bishop, K.S. On the 
existence of a hitherto unrecognized 
dietary factor essential for reproduction. 
Science 1922, 56, 650-651.
[4] Ute C. Obermuller-Jevic, Lester 
Packer. Vitamin E. Encyclopedia of 
Biological Chemistry 2004, 
Pages 384-388
[5] Institute of Medicine. Food and 
Nutrition Board. Dietary Reference 
Intakes: Vitamin C, Vitamin E, 
Selenium, and Carotenoids. 






[8] Sheppard, A.J.; Pennington, 
J.A.T.;Weihrauch, J.L. Analysis and 
distribution of vitamin E in vegetable 
oils and foods. In Vitamin E in Health 
and Disease; Packer, L., Fuchs, J., Eds.; 
Marcel Dekker: New York, NY, USA, 
1993; pp. 9-31, ISBN 0-8247-8692-0.
[9] Ramaswamy, K.; Subash, C.G.; Ji, 
H.K.; Bharat, B.A. Tocotrienols fight 
cancer by targeting multiple cell 
signaling pathways. Genes Nutr. 2012, 
7, 43-52.
[10] Kobayashi, H.; Kanno, C.; 
Yamauchi, K.; Tsugo, T. Identification of 
alpha-, beta-, gamma-, and delta-
tocopherols and their contents in human 
milk. Biochim. Biophys. Acta 1975, 380, 
282-290.
[11] Bunnel RH, Keating J, Quaresimo A, 
Parman GK. Alpha-tocopherol content 
of foods. Am J Clin Nutr. 1965; 17:1-10.
[12] Aggarwal BB, Sundaram C, 
Prasad S, Kannappan R. Tocotrienols, 
the vitamin E of the 21st century: it’s 
potential against cancer and other 
chronic diseases. Biochemical 
pharmacology. 2010 Dec 
1;80(11):1613-31
[13] Mohd Mutalip SS, Ab-Rahim S, 
Rajikin MH. Vitamin E as an antioxidant 
in female reproductive health. 
Antioxidants. 2018 Feb;7(2):22.
[14] Borel P, Preveraud D, 
Desmarchelier C. Bioavailability of 
vitamin E in humans: an update. 
Nutrition reviews. 2013 Jun 1; 
71(6):319-31.
[15] Gagné A, Wei SQ , Fraser WD, 
Julien P. Absorption, transport, and 
bioavailability of vitamin e and its role 
in pregnant women. Journal of 
Obstetrics and Gynaecology Canada. 
2009 Mar 1;31(3):210-7
[16] Scholl TO, Chen X, Sims M, 
Stein TP. Vitamin E: maternal 
concentrations are associated with fetal 
growth. The American journal of 
clinical nutrition. 2006 Dec 1; 
84(6):1442-8.
[17] Shahidi F, Ambigaipalan P. 
Phenolics and polyphenolics in foods, 
beverages and spices: Antioxidant 
activity and health effects–A review. 
Journal of functional foods. 2015 Oct 
1;18:820-97
[18] Shahidi F, De Camargo AC. 
Tocopherols and tocotrienols in 
References
15
Role of Vitamin E in Pregnancy
DOI: http://dx.doi.org/10.5772/intechopen.97268
common and emerging dietary sources: 
Occurrence, applications, and health 
benefits. International journal of 
molecular sciences. 2016 
Oct;17(10):1745.
[19] Nagy, K., Ramos, L., Courtet-
Compondu, M.-C., Braga-Lagache, S., 
Redeuil, K., Lobo, B., Azpiroz, F., 
Malagelada, J-R., Beaumont, M., 
Moulin, J., Acquistapache, S., 
Sagalowicz, L., Kussmann, M., Santos, 
J., Holst, B., & Williamson, G. (2013). 
Double-balloon jejunal perfusion to 
compare absorption of vitamin E and 
vitamin E acetate in healthy volunteers 
under maldigestion conditions. 
European Journal of Clinical Nutrition, 
67(2), 202-206. PMid: 23212132. http:// 
dx.doi.org/10.1038/ejcn.2012.183
[20] Herrera E, Barbas C. Vitamin E: 
action, metabolism and perspectives. 
Journal of physiology and biochemistry. 
2001 Mar 1;57(1):43-56
[21] Meier R, Tomizaki T, 
Schulze-Briese C, Baumann U, 
Stocker A. The molecular basis of 
vitamin E retention: structure of human 
α-tocopherol transfer protein. Journal of 
molecular biology. 2003 Aug 15; 
331(3):725-34.
[22] Drevon CA. Absorption, transport 
and metabolism of vitamin E. Free 
radical research communications. 1991 
Jan 1; 14(4):229-46.
[23] Rizvi S, Raza ST, Faizal Ahmed AA, 
Abbas S, Mahdi F. The role of vitamin E 
in human health and some diseases. 
Sultan Qaboos University Medical 
Journal. 2014 May;14(2):e157
[24] Bjørneboe A, Bjørneboe GE, 
Drevon CA. Absorption, transport and 
distribution of vitamin E. the Journal of 
Nutrition. 1990 Mar 1;120(3):233-42.
[25] Krinsky NI, Beecher GR, Burk RF, 
Chan AC, Erdman JJ, Jacob RA, Jialal I, 
Kolonel LN, Marshall JR, Taylor 
Mayne PR, Prentice RL. Dietary 
reference intakes for vitamin C, vitamin 
E, selenium, and carotenoids. Institute 
of Medicine. 2000 Apr 19.
[26] Schmölz L, Birringer M, 
Lorkowski S, Wallert M. Complexity of 
vitamin E metabolism. World journal of 
biological chemistry. 2016 Feb 
26;7(1):14.
[27] Debbie J.Mustacich, 
Richard S.Bruno, Maret G.Traber. 
Vitamin E Vitamins & Hormones 
,Volume 76, 2007, Pages 1-210
[28] Rumbold A, Ota E, Hori H, 
Miyazaki C, Crowther CA. Vitamin E 
supplementation in pregnancy. 
Cochrane Database of Systematic 
Reviews. 2015(9).
[29] Gagne A, Wei SQ , Fraser WD, 
Julien P. Absorption, transport, and 
bioavailability of vitamin e and its role 
in pregnant women. J Obstet Gynaecol 
Can. 2009; 31(3):210-7.
[30] Wahid S, Khan RA, Feroz Z. 
Reduction in mortality and 
teratogenicity following simultaneous 
administration of folic acid and vitamin 
E with antiepileptic, antihypertensive 
and anti-allergic drugs. J Pharm 
Bioallied Sci. 2014;6(3):185-91
[31] Hubalek M, Buchner H, Mörtl MG, 
Schlembach D, Huppertz B, Firulovic B, 
Köhler W, Hafner E, Dieplinger B, 
Wildt L, Dieplinger H. The vitamin 
E-binding protein afamin increases in 
maternal serum during pregnancy. 
Clinica Chimica Acta. 2014 Jul 1;434:41
[32] Ruder EH, Hartman TJ, 
Goldman MB. Impact of oxidative stress 
on female fertility. Current opinion in 
obstetrics & gynecology. 2009 
Jun;21(3):219
[33] Cooper DR, Kling OR, Carpenter 
MP: Effect of vitamin E deficiency on 
serum concentrations of follicle 
Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects
16
stimulating hormone and testosterone 
during testicular maturation and 
degeneration. Endocrinology 120: 
83-90, 1987
[34] Rengaraj D, Hong YH. Effects of 
dietary vitamin E on fertility functions 
in poultry species. International journal 
of molecular sciences. 2015 May; 
16(5):9910-21.
[35] Suleiman SA, Ali ME, Zaki ZM, 
el-Malik EM, Nasr MA. Lipid 
peroxidation and human sperm 
motility: protective role of vitamin E. J 
Androl. 1996;17(5):530-537.
[36] Ross C, Morriss A, Khairy M, et al. 
A systematic review of the effect of oral 
antioxidants on male infertility. Reprod 
Biomed Online. 2010;20(6):711-723.
[37] Cicek N, Eryilmaz OG, Sarikaya E, 
Gulerman C, Genc Y. Vitamin E effect 
on controlled ovarian stimulation of 
unexplained infertile women. Journal of 
assisted reproduction and genetics. 2012 
Apr 1;29(4):325-8.
[38] Das P, Chowdhury M. Vitamin 
E-deficiency induced changes in ovary 
and uterus. Molecular and cellular 
biochemistry. 1999 Aug; 198(1):151-6.
[39] Vitale SG, Capriglione S, 
Peterlunger I, La Rosa VL, Vitagliano A, 
Noventa M, Valenti G, Sapia F, 
Angioli R, Lopez S, Sarpietro G. The 
role of oxidative stress and membrane 
transport systems during endometriosis: 
a fresh look at a busy corner. Oxidative 
medicine and cellular longevity. 2018 
Mar 21;2018.
[40] Nnoaham KE, Hummelshoj L, 
Webster P, d’Hooghe T, de Cicco 
Nardone F, de Cicco Nardone C, 
Jenkinson C, Kennedy SH, 
Zondervan KT, Study WE. Impact of 
endometriosis on quality of life and 
work productivity: a multicenter study 
across ten countries. Fertility and 
sterility. 2011 Aug 1;96(2):366-73.
[41] Santanam N, Kavtaradze N, 
Murphy A, Dominguez C, 
Parthasarathy S. Antioxidant 
supplementation reduces 
endometriosis-related pelvic pain in 
humans. Translational Research. 2013 
Mar 1;161(3):189-95.
[42] Gupta S, Goldberg JM, Aziz N, 
Goldberg E, Krajcir N, Agarwal A. 
Pathogenic mechanisms in 
endometriosis-associated infertility. 
Fertil Steril. 2008; 90:247-57.
[43] Stratton P, Berkley KJ. Chronic 
pelvic pain and endometriosis: 
translational evidence of the 
relationship and implications. Hum 
Reprod Update. 2011; 17:327-46.
[44] Sinha A, Gupta S. The role of 
antioxidant supplementation in 
endometriosis therapy. J Gynecol 
Women’s Health. 2017;3.
[45] Ménézo Y, Dale B, Cohen M. DNA 
damage and repair in human oocytes 
and embryos: a review. Zygote. 2010 
Nov; 18(4):357-65.
[46] Gupta S, Sinha A. Potential markers 
of endometriosis: Latest update. Journal 
of Genital System & Disorders. 2018 Feb 
21; 2016.
[47] Santanam N, Kavtaradze N, 
Murphy A, Dominguez C, 
Parthasarathy S. Antioxidant 
supplementation reduces 
endometriosis-related pelvic pain in 
humans. Translational Research. 2013 
Mar 1; 161(3):189-95.
[48] East-Powell M, Reid R. Medical 
synopsis: Antioxidant supplementation 
may support reduction in pelvic pain in 
endometriosis. Advances in Integrative 
Medicine. 2019 Dec 1;6(4):181-2.
[49] Hashemi Z, Sharifi N, Khani B, 
Aghadavod E, Asemi Z. The effects of 
vitamin E supplementation on 
endometrial thickness, and gene 
17
Role of Vitamin E in Pregnancy
DOI: http://dx.doi.org/10.5772/intechopen.97268
expression of vascular endothelial 
growth factor and inflammatory 
cytokines among women with 
implantation failure. The Journal of 
Maternal-Fetal & Neonatal Medicine. 
2019 Jan 2;32(1):95-102.
[50] Kavtaradze N, Dominguez CE, 
Rock JA, Parthasarathy S, Murphy AA. 
Vitamin E and C supplementation 
reduces endometriosis related pelvic 
pain. Fertility and Sterility. 2003 Sep 1; 
80:221-2.
[51] Rumbold A, Middleton P, Pan N, 
Crowther CA. Vitamin supplementation 
for preventing miscarriage. Cochrane 
Database of Systematic Reviews. 
2011(1).
[52] Shamim, A.A.; Schulze, K.; Merrill, 
R.D.; Kabir, A.; Christian, P.; Shaikh, S.; 
Wu, L.; Ali, H.; Labrique, A.B.; Mehra, 
S.; et al. Tocopherols are associated with 
risk of miscarriage in rural Bangladesh. 
Am. J. Clin. Nutr. 2015, 101, 294-301.
[53] Rumbold AR, Maats FH, 
Crowther CA. Dietary intake of vitamin 
C and vitamin E and the development of 
hypertensive disorders of pregnancy. 
European Journal of Obstetrics & 
Gynecology and Reproductive Biology. 
2005 Mar 1; 119(1):67-71.
[54] Wangkheimayum S, Kumar S, 
Suri V. Effect of vitamin E on sP-selectin 
levels in pre-eclampsia. Indian Journal 
of Clinical Biochemistry. 2011 Apr 
1;26(2):169-71.
[55] See AW, Clagett-Dame M. The 
temporal requirement for vitamin A in 
the developing eye: mechanism of 
action in optic fissure closure and new 
roles for the vitamin in regulating cell 
proliferation and adhesion in the 
embryonic retina. Developmental 
biology. 2009 Jan 1; 325(1):94-105.
[56] Pourmasumi S, Ghasemi N, 
Talebi AR, Mehrabani M, Sabeti P. The 
effect of vitamin E and selenium on 
sperm chromatin quality in couples with 
recurrent miscarriage. International 
Journal of Medical Laboratory. 2018 Feb 
10;5(1):1-0.
[57] Chen H, Qian N, Yan L, Jiang H. 
Role of serum vitamin A and E in 
pregnancy. Experimental and 
therapeutic medicine. 2018 Dec 1; 
16(6):5185-9.
[58] Kurmacheva NA, Verizhnikova EV, 
Chernyshova GY, Chernenkov YV, 
Kharitonova OM. Clinical and economic 
feasibility study of the use of vitamin 
and mineral complexes in case of 
miscarriage. Gynecology. 2017 Dec 
15;19(6):4-10.
[59] Shamim AA, Schulze K, Merrill RD, 
Kabir A, Christian P, Shaikh S, Wu L, 
Ali H, Labrique AB, Mehra S, 
Klemm RD. First-trimester plasma 
tocopherols are associated with risk of 
miscarriage in rural Bangladesh. The 
American journal of clinical nutrition. 
2015 Feb 1;101(2):294-301
[60] Junovich G, Dubinsky V, Gentile T, 
Sarto A, Pasqualini S, Gutiérrez G. 
Comparative immunological effect of 
anticoagulant and antioxidant therapy 
in the prevention of abortion in mice. 
American Journal of Reproductive 
Immunology. 2011 Feb;65(2):104-9.
[61] Şimşek M, Naziroǧlu M, Şimşek H, 
Cay M, Aksakal M, Kumru S. Blood 
plasma levels of lipoperoxides, 
glutathione peroxidase, beta carotene, 
vitamin A and E in women with 
habitual abortion. Cell Biochemistry 
and Function: Cellular biochemistry 
and its modulation by active agents or 
disease. 1998 Dec;16(4):227-31.
[62] Vural P, Akgül C, Yildirim A, 
Canbaz M. Antioxidant defence in 
recurrent abortion. Clinica chimica acta. 
2000 May 1;295(1-2):169-77.
[63] Von Mandach U, Huch R, Huch A. 
Maternal and cord serum vitamin E 
Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects
18
levels in normal and abnormal 
pregnancy. International journal for 
vitamin and nutrition research. 
Internationale Zeitschrift fur Vitamin-
und Ernahrungsforschung. Journal 
international de vitaminologie et de 
nutrition. 1994 Jan 1;64(1):26-32.
[64] Oladimeji OS, Magbagbeola OA, 
Peter SS, Adewole TA, Akinwande IA. 
Serum Vitamin E, Cholesterol and 
Triglyceride Levels of Nigerian Women 
with Unexplained Infertility and 
Recurrent Miscarriage. Nigerian Journal 
of Health and Biomedical Sciences. 
2002; 1(2):71-5.
[65] Saul AW. Not taking supplements 
causes miscarriage, birthing problems, 
infant mortality.
[66] Bellver J, Rodríguez-Tabernero L, 
Robles A, Muñoz E, Martínez F, 
Landeras J, García-Velasco J, Fontes J, 
Álvarez M, Álvarez C, Acevedo B. 
Polycystic ovary syndrome throughout a 
woman’s life. Journal of assisted 
reproduction and genetics. 2018 Jan 
1;35(1):25-39.
[67] Wong SK, Chin KY, Suhaimi FH, 
Ahmad F, Ima-Nirwana S. Vitamin E as 
a potential interventional treatment for 
metabolic syndrome: Evidence from 
animal and human studies. Frontiers in 
pharmacology. 2017 Jul 5; 8:444.
[68] Di˙ ncer Y, Akcay T, Erdem T, Ilker 
Saygi˙ li˙ E, Gundogdu S. DNA damage, 
DNA susceptibility to oxidation and 
glutathione level in women with 
polycystic ovary syndrome. 
Scandinavian journal of clinical and 
laboratory investigation. 2005 Jan 
1;65(8):721-8.
[69] Oyebanji OG, Asaolu MF. 
Assessment of antioxidant status of 
women with polycystic ovarian 
syndrome. Asian Pacific Journal of 
Reproduction. 2020 Jan 1; 9(1):9.
[70] Mohan SK, Priya VV. Lipid 
peroxidation, glutathione, ascorbic acid, 
vitamin E, antioxidant enzyme and 
serum homocysteine status in patients 
with polycystic ovary syndrome. 
Biology and Medicine. 2009;1(3):44-9.
[71] Hamad AW, Ahmad SA, 
Rasheed FA. Comparative study of 
antioxidant levels (Vitamin E 
&Selenium) in serum of polycystic 
ovary syndrome patients and control. 
Al-Nahrain Journal of Science. 
2011;14(1).
[72] Shirazi S, Gargari BP, Izadi A, 
Taghizadeh S, Parizad M. Effect of 
vitamin E on serum levels of vascular 
endothelial growth factor and 
angiopoietin-1 in women with 
polycystic ovary syndrome: A pilot 
randomized, placebo-controlled trial. 
International Journal of Fertility & 
Sterility. 2021 Jan; 15(1):44.
[73] Talari HR, Poladchang S, 
Hamidian Y, Samimi M, Gilasi HR, 
Ebrahimi FA, Asemi Z. The Effects of 
Omega-3 and Vitamin E 
Co-supplementation on Carotid Intima-
media Thickness and Inflammatory 
Factors in Patients with Polycystic 
Ovary Syndrome. Oman Med J. 2018 
Nov;33(6):473-479
[74] Izadi A, Ebrahimi S, Shirazi S, 
Taghizadeh S, Parizad M, Farzadi L, 
Gargari BP. Hormonal and metabolic 
effects of coenzyme Q10 and/or vitamin 
E in patients with polycystic ovary 
syndrome. The Journal of Clinical 
Endocrinology & Metabolism. 2019 
Feb; 104(2):319-27.
[75] Shrek, S (1 December 2013). 
"Prenatal Development Definition and 
Patient Education". Archived from the 
original on 1 December 2013. Retrieved 
21 April 2020.
[76] Takenaka M, Horiuchi T, 
Yanagimachi R. Effects of light on 
development of mammalian zygotes. 
Proceedings of the National Academy of 
Sciences. 2007 Sep 4; 104(36):14289-93.
19
Role of Vitamin E in Pregnancy
DOI: http://dx.doi.org/10.5772/intechopen.97268
[77] Kasterstein E, Strassburger D, 
Komarovsky D, Bern O, Komsky A, 
Raziel A, Friedler S, Ron-El R. The 
effect of two distinct levels of oxygen 
concentration on embryo development 
in a sibling oocyte study. Journal of 
assisted reproduction and genetics. 2013 
Aug;30(8):1073-9.
[78] Arias ME, Sanchez R, Felmer R. 
Evaluation of different culture systems 
with low oxygen tension on the 
development, quality and oxidative 
stress-related genes of bovine embryos 
produced in vitro. Zygote. 2012 Aug 1; 
20(3):209.
[79] Tsujii H, Miah AG, and Salma U. 
Effect of Selenium and Vitamin E on 
Development and Viability of 
Preimplanted Mouse Embryo.2017, 
Journal of Dairy & Veterinary Sciences , 
2(5): 1-7
[80] McDougall M, Choi J, Truong L, 
Tanguay R, Traber MG. Vitamin E 
deficiency during embryogenesis in 
zebrafish causes lasting metabolic and 
cognitive impairments despite refeeding 
adequate diets. Free Radical Biology and 
Medicine. 2017 Sep 1;110:250-60
[81] Nour NM. Premature delivery and 
the millennium development goal. 
Reviews in obstetrics and gynecology. 
2012; 5(2):100.
[82] Cruz CS, Wimberley PD, 
Johansen K, Friis-Hansen B. The effect 
of vitamin E on erythrocyte hemolysis 
and lipid peroxidation in newborn 
premature infants. Acta Pædiatrica. 
1983 Nov; 72(6):823-6.
[83] Hittner HM, Godio LB, Rudolph AJ, 
Adams JM, Garcia-Prats JA, 
Friedman Z, Kautz JA, Monaco WA. 
Retrolental fibroplasia: efficacy of 
vitamin E in a double-blind clinical 
study of preterm infants. New England 
journal of medicine. 1981 Dec 
3;305(23):1365-71.
[84] Melhorn DK, Gross S, Childers G. 
Vitamin E-dependent anemia in the 
premature infant. II. Relationships 
between gestational age and absorption 
of vitamin E. The Journal of pediatrics. 
1971 Oct 1; 79(4):581-8.
[85] Bell EF, Filer Jr LJ. The role of 
vitamin E in the nutrition of  
premature infants. The American 
journal of clinical nutrition. 1981 Mar 1; 
34(3):414-22.
[86] Stewart EA. Uterine fibroids. The 
Lancet. 2001 Jan 27; 357(9252):293-8.
[87] Guo XC, Segars JH. The impact and 
management of fibroids for fertility: an 
evidence-based approach. Obstetrics 
and Gynecology Clinics. 2012 Dec 1; 
39(4):521-33.
[88] Harrison SA, Torgerson S, 
Hayashi P, Ward J, Schenker S. Vitamin 
E and vitamin C treatment improves 
fibrosis in patients with nonalcoholic 
steatohepatitis. The American journal of 
gastroenterology. 2003 Nov 1; 
98(11):2485-90.
[89] Fruscella L, Ciaglia EM, Danti M, 
Fiumara D. Vitamin E in the treatment 
of pregnancy complicated by uterine 
myoma. Minerva Ginecologica. 1997 
Apr 1; 49(4):175-9.
[90] Wells SR, Jennings MH, Rome C, 
Hadjivassiliou V, Papas KA, 
Alexander JS. Alpha-, gammaand 
delta-tocopherols reduce inflammatory 
angiogenesis in human microvascular 
endothelial cells. The Journal of 
nutritional biochemistry. 2010 Jul 
1;21(7):589-97.
[91] Young SL, Al-Hendy A, Copland JA. 
Potential nonhormonal therapeutics for 
medical treatment of leiomyomas. In 
Seminars in reproductive medicine 2004 
May (Vol. 22, No. 02, pp. 121-130). 
Copyright© 2004 by Thieme Medical 
Publishers, Inc., 333 Seventh Avenue, 
New York, NY 10001, USA.
Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects
20
[92] Zhang Y, Ni J, Messing EM, 
Chang E, Yang CR, Yeh S. Vitamin E 
succinate inhibits the function of 
androgen receptor and the expression of 
prostate-specific antigen in prostate 
cancer cells. Proceedings of the National 
Academy of Sciences. 2002 May 
28;99(11):7408-13
[93] Akyol D, Mungan T, Görkemli H, 
Nuhoglu G. Maternal levels of vitamin E 
in normal and preeclamptic pregnancy. 
Archives of gynecology and obstetrics. 
2000 Apr 1; 263(4):151-5.
[94] Brown MA, Lindheimer MD, de 
Swiet M, Assche AV, Moutquin JM. The 
classification and diagnosis of the 
hypertensive disorders of pregnancy: 
statement from the International 
Society for the Study of Hypertension in 
Pregnancy (ISSHP).
[95] Poston L, Raijmakers M, Kelly F. 
Vitamin E in preeclampsia. Annals of 
the New York Academy of Sciences. 
2004 Dec; 1031(1):242-8.
[96] Shennan AH, Duckworth S. Use of 
vitamin C and E to prevent 
preeclampsia. Obstetric medicine. 2010 
Sep;3(3):121-2
[97] Salles AM, Galvao TF, Silva MT, 
Motta LC, Pereira MG. Antioxidants for 
preventing preeclampsia: a systematic 
review. The Scientific World Journal. 
2012 Apr 19; 2012.
[98] Kharb S. Vitamin E and C in 
preeclampsia. European Journal of 
Obstetrics & Gynecology and 
Reproductive Biology. 2000 Nov 1; 
93(1):37-9.
[99] Brodsky D, Christou H. Current 
concepts in intrauterine growth 
restriction. Journal of intensive care 
medicine. 2004 Nov; 19(6):307-19.
[100] Nardozza LM, Júnior EA, 
Barbosa MM, Caetano AC, Lee DJ, 
Moron AF. Fetal growth restriction: 
current knowledge to the general Obs/
Gyn. Archives of gynecology and 
obstetrics. 2012 Jul 1; 286(1):1-3.
[101] Sales F, Peralta OA, Narbona E, 
McCoard S, Lira R, De Los Reyes M, 
González-Bulnes A, Parraguez VH. 
Maternal supplementation with 
antioxidant vitamins in sheep results in 
increased transfer to the fetus and 
improvement of fetal antioxidant status 
and development. Antioxidants. 2019 
Mar; 8(3):59.
[102] Silva AB, Medeiros JF, Lima MS, 
Mata AM, Andrade ED, Bezerra DS, 
Osório MM, Dimenstein R, Ribeiro KD. 
Intrauterine growth and the vitamin e 
status of full-term and preterm 
newborns. Revista Paulista de Pediatria. 
2019 Sep; 37(3):291-6.
[103] Busso D, Mascareño L, Salas F, 
Berkowitz L, Santander N, Quiroz A, 
Amigo L, Valdés G, Rigotti A. Early 
onset intrauterine growth restriction in 
a mouse model of gestational 
hypercholesterolemia and 
atherosclerosis. BioMed research 
international. 2014 Jan 1; 2014.
[104] Shubert PJ, Diss E, Iams JD. 
Etiology of preterm premature rupture 
of membranes. Obstetrics and 
gynecology clinics of North America. 
1992 Jun 1; 19(2):251-63.
[105] Plessinger MA, Woods Jr JR, 
Miller RK. Pretreatment of human 
amnion-chorion with vitamins C and E 
prevents hypochlorous acid–induced 
damage. American journal of obstetrics 
and gynecology. 2000 Oct 
1;183(4):979-85
[106] Bolisetty S, Naidoo D, Lui K, 
Koh TH, Watson D, Whitehall J. 
Antenatal supplementation of 
antioxidant vitamins to reduce the 
oxidative stress at delivery—a pilot 
study. Early human development. 2002 
Apr 1;67(1-2):47-53
[107] Woods Jr JR, Plessinger MA, 
Miller RK. Vitamins C and E: missing 
21
Role of Vitamin E in Pregnancy
DOI: http://dx.doi.org/10.5772/intechopen.97268
links in preventing preterm premature 
rupture of membranes? American 
journal of obstetrics and gynecology. 
2001 Jul 1; 185(1):5-10.
[108] Hauth JC, Clifton RG, Roberts JM, 
Spong CY, Myatt L, Leveno KJ, 
Pearson GD, Varner MW, Thorp Jr JM, 
Mercer BM, Peaceman AM. Vitamin C 
and E supplementation to prevent 
spontaneous preterm birth. Obstetrics 
and gynecology. 2010 Sep;116(3):653.
[109] Al-Gubory KH. Environmental 
pollutants and lifestyle factors induce 
oxidative stress and poor prenatal 
development. Reproductive 
BioMedicine Online. 2014 Jul 1; 
29(1):17-31.
[110] Anderson K, Nisenblat V, 
Norman R. Lifestyle factors in people 
seeking infertility treatment–a review. 
Australian and New Zealand journal of 
obstetrics and gynaecology. 2010 Feb; 
50(1):8-20.
[111] Sharma R, Biedenharn KR, 
Fedor JM, Agarwal A. Lifestyle factors 
and reproductive health: taking control 
of your fertility. Reproductive biology 
and endocrinology. 2013 Dec; 11(1):1-5.
[112] Al-Gubory KH, Fowler PA, 
Garrel C. The roles of cellular reactive 
oxygen species, oxidative stress and 
antioxidants in pregnancy outcomes. 
The international journal of 
biochemistry & cell biology. 2010 Oct 1; 
42(10):1634-50.
[113] Agarwal A, Aponte-Mellado A, 
Premkumar BJ, Shaman A, Gupta S. The 
effects of oxidative stress on female 
reproduction: a review. Reproductive 
biology and endocrinology. 2012 Dec; 
10(1):1-31.
[114] Evans MD, Dizdaroglu M, 
Cooke MS. Oxidative DNA damage and 
disease: induction, repair and 
significance. Mutation Research/
Reviews in Mutation Research. 2004 Sep 
1; 567(1):1-61.
[115] Finaud J, Lac G, Filaire E. Oxidative 
stress. Sports medicine. 2006 Apr 1; 
36(4):327-58.
[116] Agarwal A, Gupta S, Sharma R. 
Oxidative stress and its implications in 
female infertility–a clinician's 
perspective. Reproductive biomedicine 
online. 2005 Jan 1; 11(5):641-50.
[117] Agarwal A, Allamaneni SS, 
Said TM. Chemiluminescence technique 
for measuring reactive oxygen species. 
Reproductive BioMedicine Online. 2004 
Jan 1; 9(4):466-8.
[118] Agarwal A, Nallella KP, 
Allamaneni SS, Said TM. Role of 
antioxidants in treatment of male 
infertility: an overview of the literature. 
Reproductive biomedicine online. 2004 
Jan 1; 8(6):616-27.
[119] Harvey AJ, Kind KL, Thompson JG. 
REDOX regulation of early embryo 
development. Reproduction-
Cambridge-. 2002 Apr 1; 123(4):479-86.
[120] Dennery PA. Role of redox in fetal 
development and neonatal diseases. 
Antioxidants and Redox Signaling. 2004 
Feb 1; 6(1):147-53.
[121] Myatt L, Cui X. Oxidative stress in 
the placenta. Histochemistry and cell 
biology. 2004 Oct 1; 122(4):369-82.
[122] Sikkema JM, van Rijn BB, Franx A, 
Bruinse HW, de Roos R, Stroes ES, et al. 
Placental superoxide is increased in 
pre-eclampsia. Placenta. 2001; 22: 
304-308.
[123] Fraser WD, Audibert F, Bujold E, 
Leduc L, Xu H, Boulvain M, Julien P. 
The vitamin E debate: implications for 
ongoing trials of pre-eclampsia 
prevention. BJOG: an international 
journal of obstetrics and gynaecology. 
2005 Jun 1; 112(6):684-8.
Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects
22
[124] Poston L, Chappell L, Seed P, 
Shennan A. Biomarkers of oxidative 
stress in pre-eclampsia. Pregnancy 
Hypertension: An International Journal 
of Women's Cardiovascular Health. 2011 
Jan 1; 1(1):22-7.
[125] Burton GW, Foster DO, Perly B, 
Slater TF, Smith IC, Ingold KU. 
Biological antioxidants. Philosophical 
Transactions of the Royal Society of 
London. B, Biological Sciences. 1985 
Dec 17; 311(1152):565-78.
